Science VC
✓

Science VC

על אודות פודקאסט זה 🔗

Science VC explores the intersection of deeptech startups and venture capital. Each episode features conversations with startup founders, venture capitalists, and industry experts. Discover their stories, lessons learned, and predictions for the future.  

Learn more about the challenges and opportunities of fundraising for venture-backed startups innovating in agtech, biotech, energy, foodtech, healthtech, and sustainability.

טכנולוגיה
יזמות
עסקים
מנחים:
תדירות עדכון:
weekly
אורך אודיו ממוצע:
57 minutes
ראיונות אורחים
פודקאסט וידאו
אנגלית
ארצות הברית
8 פרקים
מאז 27 בפברואר 2025
episodic
השתמש ב-APIכדי להביא את הפודקאסט הזה ב-JSON

בפודקסט זה 🔗

ערוך תגיות אלה

הפרק החדש ביותר 🔗

Why Not All Traction Is Equal | Aligning Latam’s Agtech Innovation with Industry Needs | The Role of LPs in Early VC Investing | Long-Term Thinking in Fundraising, with Galit Flasterstein, Managing Partner @ Danta Fund | Ep 8

Why Not All Traction Is Equal | Aligning Latam’s Agtech Innovation with Industry Needs | The Role of LPs in Early VC Investing | Long-Term Thinking in Fundraising, with Galit Flasterstein, Managing Partner @ Danta Fund | Ep 8

Biodiversity as an AdvantageGalit is a Managing Partner at Danta Fund, a VC firm that backs early-stage agritech startups in Latin America. Danta Fund has the mission of filling three main voids in Latin America: funding in early-stage agri-tech startups, mentorship to guide their founders, and co‮…
00:54:46
שתף
שמור

חיפוש פרקים ישנים

חפש פרקים קודמים של Science VC.
הטמע סרגל חיפוש זה לאתר שלך

פרקים קודמים

Unlocking Unsung Potential | LATAM Biotech’s Global Path | What Investors Really Look For | Avoiding Unforced Errors | Why Tulsa? | Building Cross-Border Deeptech Startups, with Michael Basch, GP and CEO @ Atento Capital | Ep 7

Unlocking Unsung Potential | LATAM Biotech’s Global Path | What Investors Really Look For | Avoiding Unforced Errors | Why Tulsa? | Building Cross-Border Deeptech Startups, with Michael Basch, GP and CEO @ Atento Capital | Ep 7

Why not Tulsa?Michael is the Founder, CEO, and General Partner of Atento Capital, a pre-seed and seed-stage VC firm focused on partnering with founders to build technology around healthcare, climate-tech, and business services.Topics in this episode0:00 Intro1:13 Michael’s Career Journey: From Fou‮…
00:52:53
שתף
שמור
Why No Idea Is Truly Unique | Leveraging Warm Intros and Mentorships | Communicating Urgency and Opportunities to VCs | Success Beyond Funding | Inside NYU’s Acceleration Program with Khoa Ma, Associate Director @ Endless Frontier Labs | Ep 6

Why No Idea Is Truly Unique | Leveraging Warm Intros and Mentorships | Communicating Urgency and Opportunities to VCs | Success Beyond Funding | Inside NYU’s Acceleration Program with Khoa Ma, Associate Director @ Endless Frontier Labs | Ep 6

Are there unique ideas anymore?Khoa Ma is an Associate Director at Endless Frontier Labs, a program at NYU Stern School of Business for early-stage science and technology startups. Topics in this episode0:00 Intro1:07 Khoa’s Career Path3:22 How Endless Frontier Labs Evaluates Startups8:45 What Get‮…
01:03:13
שתף
שמור
Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana, CEO @ APEXzymes | Ep 5

Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana, CEO @ APEXzymes | Ep 5

Can a single innovation unlock multiple billion-dollar markets?Larissa is the CEO of APEXzymes, a Brazilian biotech startup that produces cost-effective enzymes for sustainable industrial applications. During our conversation, Larissa shares her journey from chemical engineering to venture capital‮…
00:57:22
שתף
שמור
The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT Systems | Ep 4

Is it possible to transform carbon emissions into everyday products?Alex is the CEO of CERT Systems, a Canadian climatetech startup that converts CO2 emissions into high-value chemicals. In this episode, Alex shares his journey from the lab bench to raising non-dilutive capital. Topics in this epi‮…
00:58:04
שתף
שמור
Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

There is a lot of stigma around psychedelics.Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.Topics in this episod‮…
00:55:55
שתף
שמור
Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego Stone, CEO @ Qnity | Ep 2

Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego Stone, CEO @ Qnity | Ep 2

Investors don’t care how fancy your tech is.Diego is the CEO of Qnity, a pharmatech startup that uses quantum electrochemistry to develop devices for drug discovery and screening. In this episode, we discuss his lessons as a second-time founder and his insights on fundraising in the deeptech space‮…
00:59:23
שתף
שמור
Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round, with Gerardo Bluske, CBO @ ByBug | Ep 1

Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round, with Gerardo Bluske, CBO @ ByBug | Ep 1

Why do founders have to be very picky about what VCs they approach?Gerardo Bluske is the Chief Business Officer of ByBug, a biotech startup that creates therapeutics for animals using black soldier flies. In this episode, Gerardo shares his insights about business development and fundraising.Topic‮…
00:56:05
שתף
שמור
צפית בכל הפרקים של פודקסט זה
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-JP Orlov, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
מנוע חיפוש PODCAST
אתה יכול להשתמש באתר שלנו כדי לחפש3,826,022פודקאסטים ופודקאסטים195,980,670לפי אנשים, מקומות או נושאים.
I have no special talent. I am only passionately curious, and I listen to podcasts.  ‐ Albert "Llamacorn" Einstein

המלצות

השתמש בממשק ה-API כדי להביא פודקסט זה